PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon’s Nancy Smerkanich to Present at the Drug Information Association’s 9th Annual Electronic Submissions Conference - Ms. Smerkanich joins respected industry colleagues to address Global Submission Challenges
Octagon’s Nancy Smerkanich to Present at the Drug Information Association’s 9th Annual Electronic Submissions Conference

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2010/10/25 - Ms. Smerkanich joins respected industry colleagues to address Global Submission Challenges.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Nancy Smerkanich, vice president, Global Regulatory Affairs, Octagon Research Solutions, Inc., to serve as Tutorial Instructor, Session Facilitator and Discussion Leader during the Drug Information Association’s (DIA’s) 9th Annual Electronic Submission Conference: Working Together Towards a Global Strategy. (diahome.org).

• Ms. Smerkanich also serves as Program Co-Chairperson along with Gary M. Geisinger, director (acting), Office of Business Informatics, Center for Drug Evaluation (CDER), US Food and Drug Administration (FDA).

• This year collaborative sessions have been included in the conference program to focus discussions on key topics and enable greater interaction among attendees.

• The conference will be held 27-29 October 2010 at The Westin San Diego Hotel, San Diego, CA and Ms. Smerkanich will be instructing or facilitating discussions during the following sessions to be held during the conference:

Tutorial #1 – eCTD Basics
Role: Tutorial Instructor
Date: 27 October 2010
Time: 8:30 am – 12:00 pm PDT

Tutorial #3 – US INDs in eCTD
Role: Tutorial Instructor
Date: 27 October 2010
Time: 1:30 pm – 5:00 pm PDT

Session 6: Collaborative Sessions
This group of Collaborative Sessions are comprised of three concurrent sessions for various modules of the CTD. The M2.4/2.6/4 session is a discussion of required pre-clinical information.
Collaborative Session Break-Out 2: M2.4/2.6/4
Role: Session Facilitator
Date: 29 October 2010
Time: 1:00 pm – 2:00 pm PDT

Session 7: Discussion of Collaborative Sessions
This session serves as a wrap-up discussion where each group will offer a 10-minute presentation to summarize the discussion points of their breakout session.
Role: Discussion Leader
Date: 29 October 2010
Time: 2:00 pm – 3:00 pm PDT

• Octagon will also be exhibiting during the conference at Booth #10 and will provide demonstrations of its ViewPoint® enterprise process management solution, as well as its ViewPoint eCTD Complete and StartingPoint® its global submission document authoring template suite.

Supporting Quotes

‘I am honored to be working with such a respected team of industry professionals who are interested in sharing their experiences,’ stated Ms. Smerkanich, vice president, Global Regulatory Affairs. ‘I look forward to networking with industry colleagues and facilitating informative discussions as we work together to identify and address global submission challenges.’
‘I am excited that Nancy has the opportunity to share her global regulatory affairs expertise in support of this very focused Drug Information Association conference,’ commented Jim Walker, CEO and chairman, Octagon Research Solutions, Inc. ‘Global electronic submissions continue to be a topic of much interest to our industry colleagues. This opportunity allows us to share our industry expertise and continue to position Octagon as a leader in unifying clinical data and submission strategy for the global life sciences industry.’

About Octagon Research Solutions, Inc.
Octagon (octagonresearch.com) is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in London, UK. Octagon’s EDC Operations are located in Mountain View, CA.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon’s Nancy Smerkanich to Present at the Drug Information Association’s 9th Annual Electronic Submissions Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Kathleen Bouldin - OctagonResearch.com 
610-535-8500 x5556 kbouldin[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)